A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis - Concepedia

Concepedia

Publication | Closed Access

A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis

97

Citations

33

References

2014

Year

Christopher P. Venner, Julian D. Gillmore, Sajitha Sachchithanantham, S. Mahmood, Thirusha Lane, Darren Foard, Lisa Rannigan, Simon Gibbs, Jennifer H. Pinney, Carol Whelan,

Alzheimer's DiseaseAl AmyloidosisPharmacologyMatched ComparisonRisk-adapted CyclophosphamideMedicine

References

	Year	Citations

Page 1